The results suggested that LPAR5, LPAR6, LPAR4, LPAR3, LPAR2, LPAR1, F2, ENPP2, MMP9, and TNF are potential targets for prostatitis. This evidence concerns the gene LPAR2 and urogenital neoplasm.